AbbVie Products
A list of AbbVie's proprietary pharmaceutical products is available below. This list contains products that are approved for specific countries or regions. Please refer to AbbVie.com or your local AbbVie affiliate to obtain the appropriate product information for your country or residence.
- Aluvia (lopinavir/ritonavir)
- Calcijex (calcitriol injection)
- Cardizem LA (diltiazem HCI tablets)
- Chirocaine
- Duodopa
- Ephedrine Sulfate
- Ethrane
- Forane
- Gengraf (cyclosporine oral solution, USP [MODIFIED] )
- HUMIRA (adalimumab)
- Kaletra (lopinavir/ritonavir)
- K-Tab (potassium chloride extended-release tablets, USP)
- Levophed
- Lupron
- Lupron Depot (leuprolide acetate for depot suspension)
- Mivacron
- Nimbex (cisatracurium besylate)
- Norvir (ritonavir)
- Plaquenil
- Prometrium
- Sevorane (sevoflurane)
- Ultane (sevoflurane)
- Simdax
- Survanta (beractant)
- Synagis (palivizumab)
- Tracrium
- Tridione
- Ultiva (remifentanil hydrochloride)
- Vicodin (hydrocodone bitartrate and acetaminophen tablets, USP)
- Vicoprofen (hydrocodone bitartrate and ibuprofen tablets)
- Zemplar
Abbott and AbbVie will share marketing rights on certain products. For the following proprietary pharmaceuticals, AbbVie will have marketing rights in the United States and Abbott will continue to market these products in all other approved countries or regions:
- AndroGel
- Biaxin
- Clarithromycin (clarithromycin)
- Creon
- Depakote (divalproex sodium delayed-release tablets)
- Marinol
- Mavik (trandolapril)
- Gopten (trandolapril)
- Niaspan (niacin extended-release tablets [film-coated])
- Synthroid (levothyroxine sodium tablets, USP)
- Tarka (trandolapril/verapamil HCl ER)
- Teveten (eprosartan mesylate)
- Teveten HCT (eprosartan mesylate/hydrochlorothiazide)
- TriCor (fenofibrate tablets)
- Trilipix (fenofibric acid)
For the following proprietary pharmaceuticals, AbbVie will have worldwide marketing rights except in Canada:
- Advicor (niacin extended-release/lovastatin tablets)
- Simcor (simvastatin/niacin extended-release)
For the following proprietary pharmaceutical, AbbVie will have marketing rights only in Japan:
- Luvox (Japan)
*This site contains information on products that are available only in certain countries. Some products may be marketed under different names around the world. Please refer to the local Abbott or AbbVie affiliate website to obtain the appropriate product information for your country of residence.





